SAA has been widely considered not only as a biomarker of inflammation and atherosclerosis, but also as a proinflammatory mediator that could directly stimulate the production of series of cytokines, such as TNF-α, IL-1β, MCP-1, and Lp-PLA2 [11–13]. The gene discussed is SAA1; the disease is atherosclerosis.